SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Feb. 15, 2006--InNexus Biotechnology Inc. (TSX: IXS) (OTCBB: IXSBF), an innovative antibody-driven drug development company based on SuperAntibody(TM) Technologies, today announced that it is relocating its corporate headquarters from Vancouver, Canada, effective immediately. InNexus’ new corporate address is 13208 E. Shea Blvd., Suite 200, The Mayo Clinic MCCRB Building, Scottsdale, AZ 85259. The company will maintain its current toll-free numbers and an office in Vancouver. The main telephone number for InNexus’ corporate office is 877-990-8382.
